Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03538028
What this trial is testing

A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies

Who this might be right for
Cervical CancerMicrosatellite Instability (MSI)-High Endometrial CancerGastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])+14 more
Incyte Biosciences International Sàrl 22
Not applicableWithdrawnNCT03523299
What this trial is testing

Pilot Study to Define the Immune Response Following Cryoablation of Invasive Breast Cancer

Who this might be right for
Invasive Ductal Carcinoma, Breast
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Early research (Phase 1)WithdrawnNCT01320787
What this trial is testing

18-F-Fluoroacetate as PET Imaging Agent

Who this might be right for
Brain CancerBreast CancerProstate Cancer
M.D. Anderson Cancer Center
Early research (Phase 1)Study completedNCT00471432
What this trial is testing

OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors

Who this might be right for
Bladder CancerBreast CancerKidney Cancer+4 more
NCIC Clinical Trials Group 40
Not applicableLooking for participantsNCT04049214
What this trial is testing

Perioperative Mindfulness Proposal

Who this might be right for
Breast CancerDCIS
Hoag Memorial Hospital Presbyterian 24
Early research (Phase 1)Study completedNCT01372644
What this trial is testing

Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor: A Proof of Principle Trial

Who this might be right for
Atypical Ductal Breast HyperplasiaLobular Carcinoma in Situ (LCIS)Atypical Lobular Hyperplasia (ALH) of Breast
NYU Langone Health 15
Large-scale testing (Phase 3)Study completedNCT00887536
What this trial is testing

A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer

Who this might be right for
Breast Cancer
NSABP Foundation Inc 1,613
Early research (Phase 1)Active Not RecruitingNCT03317405
What this trial is testing

Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery

Who this might be right for
Breast Carcinoma In SituBreast Ductal Carcinoma In SituBreast Lobular Carcinoma In Situ+10 more
National Cancer Institute (NCI) 32
Not applicableLooking for participantsNCT07095114
What this trial is testing

Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients.

Who this might be right for
Ductal Carcinoma in SituStage I Breast CancerStage II Breast Cancer+1 more
Barbara Ann Karmanos Cancer Institute 30
Not applicableLooking for participantsNCT04517838
What this trial is testing

Immune Response to Anti-HER2 Therapies in Patients With HER2-Positive Stage I-IV Breast Cancer

Who this might be right for
Breast AdenocarcinomaHER2-Positive Breast CarcinomaAnatomic Stage I Breast Cancer AJCC v8+3 more
Mayo Clinic 230
Testing effectiveness (Phase 2)Temporarily pausedNCT06868238
What this trial is testing

Evaluation of Novel Iron-based Lymphatic Mapping Agent, Magtrace, for Delayed Sentinel Lymph Node Biopsy (SLNB) in Ductal Carcinoma In-Situ (DCIS)

Who this might be right for
Ductal Carcinoma in Situ
University of Florida 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06724263
What this trial is testing

A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid Tumors

Who this might be right for
Recurrent Platinum-resistant Epithelial Ovarian CancerTriple Negative Breast Cancer (TNBC)Cervical Cancers+4 more
Tasly Biopharmaceuticals Co., Ltd. 120
Testing effectiveness (Phase 2)Ended earlyNCT03535506
What this trial is testing

Preoperative Palbociclib in Patients With DCIS of the Breast That Are Candidates for Surgery

Who this might be right for
DCIS
Georgetown University 17
Large-scale testing (Phase 3)Temporarily pausedNCT03077841
What this trial is testing

Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer

Who this might be right for
Ductal Breast Carcinoma In SituEarly-Stage Breast CarcinomaInvasive Breast Carcinoma+7 more
M.D. Anderson Cancer Center 928
Large-scale testing (Phase 3)Study completedNCT00003857
What this trial is testing

Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ

Who this might be right for
Breast Cancer
Radiation Therapy Oncology Group 636
Not applicableStudy completedNCT00617370
What this trial is testing

Dose-Dense Epirubicin and Cyclophosphamide (EC) Followed by Paclitaxel in Breast Cancer: Feasibility

Who this might be right for
Breast CancerAdenocarcinoma of the Breast
Memorial Sloan Kettering Cancer Center 38
Early research (Phase 1)Study completedNCT01576666
What this trial is testing

Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors

Who this might be right for
Dose EscalationSafetyPreliminary Efficacy+9 more
Novartis Pharmaceuticals 120
Testing effectiveness (Phase 2)Looking for participantsNCT06540872
What this trial is testing

Multimodal Imaging With FAPI-PET/MRI in Breast Carcinoma-In-Situ for Detection of Occult Invasive Cancer

Who this might be right for
Carcinoma, Intraductal, Noninfiltrating
Universität Münster 30
Early research (Phase 1)Ended earlyNCT02543645
What this trial is testing

Varlilumab and Atezolizumab in Patients With Advanced Cancer

Who this might be right for
Carcinoma, Renal CellKidney DiseasesKidney Neoplasms+11 more
Celldex Therapeutics 18
Very early researchEnded earlyNCT04712721
What this trial is testing

Study of [68Ga]-FF58 in Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins.

Who this might be right for
Glioblastoma MultiformeBrain NeoplasmsGastroesophageal Adenocarcinoma+1 more
Novartis Pharmaceuticals 14
Next Page